答案已发布9 来源
METiS TechBio香港IPO：股价暴涨170%，AI药物递送平台为何吸引投资者？
METiS TechBio在香港IPO募资约21.1亿港元（约2.7亿美元），发行价10.50港元，上市首日开盘28.68港元，较发行价上涨约173%。[2][10] 公司利用人工智能设计纳米材料药物递送系统，被形容为能把药物精准送达细胞的“纳米火箭”。[1][10] 香港正出现AI生物科技IPO热潮，超过10家尚未盈利的生物科技公司申请上市，投资者希望押注AI驱动的药物研发平台。[20]
8.3K0
AI 提示
openai.comCreate a landscape editorial hero image for this Studio Global article: What should investors know about METiS TechBio’s Hong Kong IPO debut, including how much its shares surged, how much money the company raise. Article summary: METiS TechBio’s Hong Kong debut was a hot AI-biotech IPO: its shares opened 173.14% above the HK$10.50 offer price at HK$28.68, while some reports said the stock rose as much as 185% intraday. The company raised about HK. Topic tags: general, general web. Reference image context from search candidates: Reference image 1: visual subject "On April 19, Metis TechBio (stylized as “METiS TechBio”) announced that it had cleared its listing hearing at Hong Kong Exchanges and Clearing (HKEX), a key step toward a Hong Kong" source context "Metis TechBio clears key listing hurdle with AI nanodelivery focus" Reference image 2: visual subject "Founded in 2020, Metis uses a
METiS TechBio在香港交易所的上市成为2026年最受关注的AI生物科技IPO之一。公司在首次公开募股中募集约21.1亿港元（约2.7亿美元），上市首日股价飙升超过170%，引发市场对AI制药技术的强烈关注。[2][
10]
这次亮眼的上市表现也反映出一个更大的趋势：投资者越来越愿意为利用人工智能改变药物研发与递送方式的公司买单。
上市首日：股价一度飙升185%
METiS TechBio的IPO发行价为每股10.50港元，共发行约2.01亿股，募集资金约21.1亿港元。[10]
股票在香港上市交易后开盘价达到28.68港元，比发行价高出约173%。在早盘交易中，股价一度上涨至接近30港元，涨幅最高约185%。[2][
12]
该交易通过香港交易所的第18C章（Chapter 18C）上市规则完成。这一规则专门为“专业科技公司”设立，允许尚未实现盈利、但具有前沿技术潜力的企业上市融资。[9]
Studio Global AI
Search, cite, and publish your own answer
Use this topic as a starting point for a fresh source-backed answer, then compare citations before you share it.
要点
- METiS TechBio在香港IPO募资约21.1亿港元（约2.7亿美元），发行价10.50港元，上市首日开盘28.68港元，较发行价上涨约173%。[2][10]
- 公司利用人工智能设计纳米材料药物递送系统，被形容为能把药物精准送达细胞的“纳米火箭”。[1][10]
- 香港正出现AI生物科技IPO热潮，超过10家尚未盈利的生物科技公司申请上市，投资者希望押注AI驱动的药物研发平台。[20]
人们还问
“METiS TechBio香港IPO：股价暴涨170%，AI药物递送平台为何吸引投资者？”的简短答案是什么？
METiS TechBio在香港IPO募资约21.1亿港元（约2.7亿美元），发行价10.50港元，上市首日开盘28.68港元，较发行价上涨约173%。[2][10]
首先要验证的关键点是什么？
METiS TechBio在香港IPO募资约21.1亿港元（约2.7亿美元），发行价10.50港元，上市首日开盘28.68港元，较发行价上涨约173%。[2][10] 公司利用人工智能设计纳米材料药物递送系统，被形容为能把药物精准送达细胞的“纳米火箭”。[1][10]
接下来在实践中我应该做什么？
香港正出现AI生物科技IPO热潮，超过10家尚未盈利的生物科技公司申请上市，投资者希望押注AI驱动的药物研发平台。[20]
接下来我应该探索哪个相关主题？
继续“中国“影子API”灰色市场：开发者如何绕过限制使用Claude、Gemini和ChatGPT”以获得另一个角度和额外的引用。
打开相关页面我应该将其与什么进行比较？
对照“六座电动SUV爆发：重塑中国高端电动车市场的新战场”交叉检查此答案。
打开相关页面继续你的研究
来源
- [1] AI Drug Delivery Startup Metis Clears Hong Kong IPO Hurdlecaixinglobal.com
AI Drug Delivery Startup Metis Clears Hong Kong IPO Hurdle ... Founded in 2020, Metis uses artificial intelligence to address complex drug delivery challenges, particularly in the development of lipid nanoparticle systems Chinese AI-driven drug delivery sta...
- [2] AI drug-delivery developer Metis shares jump after Hong Kong IPOchinadaily.com.cn
AI drug-delivery developer Metis shares jump after Hong Kong IPO By Li Jing chinadaily.com.cn Updated: 2026-05-13 13:17 ... Shares of Chinese AI drug-delivery developer Metis TechBio Co Ltd opened at HK$28.68, up 173.14 percent from its IPO price on its tra...
- [8] IPO- Company Informationetnet.com.hk
METIS TECHBIO-P Listing Date 2026/05/13 Listed Today -- -- Listing Price 10.500 - Subscription Rate6,910.96x - Guarantee One Lot Size800 lot - One Lot Success Rate0.14% ... Metis TechBio Co. is a pioneer in AI-empowered nanomaterial innovation, dedicated to...
- [9] O'Melveny Advises on First IPO of an AI Nano-Delivery Company in ...omm.com
O’Melveny Advises on First IPO of an AI Nano-Delivery Company in US$270 Million Hong Kong Chapter 18C Listing of Metis TechBiohBMay 13, 2026 ... HONG KONG—May 13, 2026— O’Melveny represented joint sponsors and other underwriters in the initial public offeri...
